Ginkgo Bioworks Holdings Inc (DNA) News

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire BOSTON, Feb. 25, 2025...

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab PR Newswire BOSTON, Feb. 21, 2025...

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation...

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation PR Newswire BOSTON...